Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020PRNewsWire • 03/11/21
Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual MeetingPRNewsWire • 12/05/20
Poseida Therapeutics Announces Clinical Hold Lifted on Phase I Autologous CAR-T Study in Prostate CancerPRNewsWire • 11/02/20
Poseida Therapeutics to Present CAR-T Manufacturing Process Optimization Data at CAR-TCR Digital Week 2020PRNewsWire • 09/16/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 08/31/20
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Poseida Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 08/28/20
Robbins LLP Is Investigating the Officers and Directors of Poseida Therapeutics, Inc. (PSTX) on Behalf of ShareholdersBusiness Wire • 08/24/20
Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020PRNewsWire • 08/20/20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Poseida Therapeutics, Inc. - PSTXPRNewsWire • 08/19/20
Poseida Shares Tank 34.5% As Prostate Cancer Drug Trial Halted After Patient's DeathBenzinga • 08/18/20
Poseida stock drops more than 30% as prostate cancer drug trial halted after patient diesMarket Watch • 08/17/20
